FindTrial
Sign In

Intrathecal Hydromorphone Combined with Liposomal Bupivacaine Transversus Abdominis Plane Block for Post-cesarean Delivery Analgesia: A Prospective Randomized Controlled Trial

Intrathecal Hydromorphone Combined with Liposomal Bupivacaine Transversus Abdominis Plane Block for Post-cesarean Delivery Analgesia: A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123449
Enrollment
Unknown
Registered
2026-04-27
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-cesarean Delivery Analgesia

Interventions

Experimental group:Transversus abdominis plane block performed with 266 mg liposomal bupivacaine
Control group:No transversus abdominis plane block performed

Sponsors

Jiangxi Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 40 years 2.Gestational age 37–42 weeks 3.ASA physical status II–III 4.Singleton pregnancy 5.Informed consent obtained

Exclusion criteria

Exclusion criteria: 1.Hypersensitivity to study drugs 2.Contraindications to neuraxial anesthesia 3.Complicated gestational diseases, including gestational diabetes mellitus, gestational hypertension, etc. 4.Body mass index (BMI)>35 kg/m² 5.Cognitive dysfunction in parturients 6.History of opioid or alcohol abuse

Design outcomes

Primary

MeasureTime frame
Numerical Rating Scale (NRS) scores at rest ;—

Secondary

MeasureTime frame
Postoperative adverse reaction monitoring;Quality of postoperative recovery in parturient;—

Countries

China

Contacts

Public ContactZhou Qun

Jiangxi Maternal and Child Health Hospital

zqwxj@163.com+86 139 7093 6268

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026